20 Nov Significant Market Activity on Monday: Microsoft, Boeing, Bristol Myers, Penn Entertainment, Arm, and Others
Stocks experienced notable movements on Monday, with various factors influencing their performance.
Microsoft (MSFT): CEO Satya Nadella announced that Sam Altman, the former Chief Executive of OpenAI, will head a new team focused on advanced AI research at Microsoft. The company’s shares rose by 2.1%.
Boeing (BA): The aerospace manufacturer saw a 4.9% increase, reaching $218.25, following an upgrade from Deutsche Bank. to Buy from Hold and raised the price target to $270 from $204.
Bristol Myers Squibb (BMY) and 2seventy bio (TSVT): Both companies experienced declines, with Bristol Myers Squibb falling by 4.1% and 2seventy bio dropping by 18%. The decision by the FDA regarding the approval of the Abecma gene therapy for earlier use has been postponed.
Penn Entertainment (PENN): BofA Global Research upgraded Penn Entertainment to Buy from Neutral, increasing the price target to $30 from $27. The stock increased by 7% to $26.28.
Arm Holdings (ARM): Wells Fargo’s initiation of coverage on Arm with an Overweight rating and a $70 price target resulted in a 6% surge in the stock, reaching $58.27.
YPF (YPF): Following Javier Milei’s victory in the country’s presidential race, shares of YPF, Argentina’s primary oil company, experienced a remarkable surge of 39%.
General Motors (GM): GM shares increased by 1.9% following the ratification of new labor deals at GM, Ford (F), and Stellantis (STLA) by the United Auto Workers. Following a self-driving technology accident, Cruise CEO Kyle Vogt has resigned from his position.
Zoom Video Communications (ZM): Analysts anticipated third-quarter earnings of $1.08 a share on revenue of $1.12 billion. The stock increased by 2% ahead of the report.
Earnings Reports: Agilent Technologies (A), Keysight Technologies (KEYS), and Trip.com (TCOM) were some of the companies anticipated to announce their earnings on Monday.
Nvidia (NVDA): Nvidia’s financial results for the fiscal third quarter stand out as a key highlight for the week and the stock rose by 1.2%.
Iovance Biotherapeutics (IOVA): Goldman Sachs initiated coverage on IOVA with a Buy rating and a price target of $12, resulting in a 7.3% surge in the stock price to $5.42.
Chegg (CHGG): Morgan Stanley downgraded Chegg to Underweight from Equal Weight, leading to a 5% decrease in the stock.
Dutch Bros (BROS): J.P. Morgan elevated Dutch Bros from Neutral to Overweight, contributing to a 2.4% surge in the stock.
Krispy Kreme (DNUT): J.P. Morgan downgraded Krispy Kreme to Neutral from Overweight, causing a 1.8% decline in the stock.
These movements reflect the dynamic nature of the stock market, influenced by company announcements, analyst actions, and broader economic factors. Investors need to stay informed and adapt their strategies accordingly.